PFE Related Hot FDA News
-
Johnson & Johnson (JNJ) Says Bapineuzumab IV in Alzheimer's Stopped
-
Pfizer (PFE) Says Bapineuzumab Co-Primary Endpoints Missed in Janssen AI-Led Phase 3; to Discontinue Program
-
FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso
-
Pfizer (PFE), Pain Therapeutics (PTIE) Receive Complete Response Letter for Remoxy (DRRX)
-
Pain Therapeutics (PTIE) Falls On Reports Painkiller Rejected by FDA
-
Pfizer (PFE), Medivation (MDVN) Report Dimebon Does Not Report Statistically Significant Results in Phase 3 HORIZON
-
Pfizer (PFE) stops clinical trials of Thelin(R) and begins a product recall
Back to PFE Stock Lookup
